Clinical Trials Directory

Trials / Unknown

UnknownNCT04153474

Exit Strategy After Percutaneous Nephrolithotomy: Large or Small Bore Tube?

Exit Strategy After Percutaneous Nephrolithotomy: Large or Small Bore Tube? Randomised Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
220 (estimated)
Sponsor
Mansoura University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Regarding to the distribution of nephrostomy tube (NT) size usage by country. There was a clear distinction between countries that used solely the small bore (SB) NT (Chile and Australia) and those that used solely the large bore (LB) NT (Czech Republic and Japan). There is also a trend toward SB NT in North America (\~75% in USA and Canada) and toward LB NT in South America (\~80% in Argentina and Mexico). In Europe the trend is equal (\~50% in Germany, France, Greece and UK). Based on previous data and in view of conflicting data about postoperative complication including extravasation, bleeding and hemoglobin change and pain between previous studies, we will conduct this randomised trial comparing SB and LB NT following PNL. Our aim to evaluate the safety of small versus large bore NT reporting complications using the Clavien-Dindo system with categorisation of PNL-specific complications

Conditions

Interventions

TypeNameDescription
PROCEDURElarge-bore nephrostomy tube (LBNT)large-bore 22 french nephrostomy tube (LBNT)
PROCEDUREsmall-bore nephrostomy tube (SBNT)small-bore 14 french nephrostomy tube (SBNT)

Timeline

Start date
2019-05-01
Primary completion
2020-02-01
Completion
2020-02-01
First posted
2019-11-06
Last updated
2019-11-06

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04153474. Inclusion in this directory is not an endorsement.